The use of statins (inhibitors of HMG-CoA reductase, a rate-limiting enzyme in cholesterol synthesis) has been shown to limit the proliferation, invasion, and migration of PCa cells and to trigger their programmed death [116]. The gene discussed is HMGCR; the disease is posterior cortical atrophy.